Fundraising FoxBioTrack Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
PAQ Therapeuticspaqtx.cominMay 2025
Developing novel KRAS degraders.
Burlington, US
Huaixiang Hao(Founder)in
Co-investorsMRL Ventures FundJJDC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.